Peter C. Weber, MD

Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Weber served as Chief Medical Officer at Cochlear Americas and was Professor and Director of Otology/Neurotology at University of Massachusetts Medical School. In previous roles, he was head of the Otology-Neurotology Department and Co-Director of the Hearing Implant Program at the Cleveland Clinic. He was also Acting Chairman in the Department of Otolaryngology-Head and Neck Surgery at the Medical University of South Carolina. He has served on the Board of Directors of the American Academy of Otolaryngology-Head and Neck Surgery and is past President of the Board of Governors for Otolaryngology.Dr. Weber received BS and MS degrees in engineering from Washington University and his medical degree from Albany Medical College. He completed his residency at the University of Pittsburgh Medical Center, a fellowship in Neurotology at the University of Iowa, and received an MBA degree from Duke University’s Fuqua School of Business. Dr. Weber has published over 100 articles in peer reviewed literature, written three books, multiple book chapters and has led several National Institutes of Health sponsored research studies. He also currently serves as editor-in-chief of the American Journal of Otolaryngology. His clinical interests include: surgery for pediatric and adult ear disease including cochlear implants; implantable hearing aids; infectious cholesteatomas; acoustic neuromas; ear tumors; skull bone lesions; facial nerve disorders and vertigo.

Publications

  • Published 10/12/2025

    Valayannopoulos V, Bance M, Carvalho DS, Greinwald JH, Harvey SA, Ishiyama A, Landry EC, Löwenheim H, Lustig LR, Manrique M, Nash R, Polo R, Pritchett CV, Rubinstein JT, Shearer AE, Del Castillo I, Anderson JJ, Corrales CE, Quigley TM, Riggs WJ, Weber P, Wilson G, Irvin SC, Hassan HE, Chen Y, Liu R, Drummond MC, Sabin LR, Musser BJ, Yancopoulos GD, Kyratsous CA, Herman GA, Baras A, Whitton JP. DB-OTO Gene Therapy for Inherited Deafness. N Engl J Med. 2026 Mar 12; 394(11):1074-1083. PMID: 41085057.

    Read at: PubMed

  • Published 8/25/2025

    Chung Y, Koehler SD, Cancelarich S, Gibson TM, Pregernig G, Becker L, Artinian QA, Goodliffe JW, Pan N, Quigley TM, Senapati A, Slade PG, Smith LM, So KS, Zhang X, Corrales CE, Weber P, Macdonald LE, Zambrowicz B, Economides AN, Kyratsous CA, Burns JC, Palermo AT, Sabin LR, Lee J, Valayannopoulos V, Whitton JP, Drummond MC. Functional, sustained recovery of hearing in Otoferlin-deficient mice using DB-OTO, a hair-cell-specific AAV-based gene therapy. Mol Ther Methods Clin Dev. 2025 Dec 11; 33(4):101577. PMID: 41036103.

    Read at: PubMed

  • Published 8/20/2025

    Patel AA, Levi JR, Weber PC. Examining the Impact of Race, Ethnicity, and Language on Pursuit of Cochlear Implantation. Clin Otolaryngol. 2026 Jan; 51(1):25-31. PMID: 40831433.

    Read at: PubMed

  • Published 6/18/2025

    Patel AA, Weber PC. Is Vestibular Assessment Necessary or Valuable in Preoperative Evaluation for Cochlear Implantation? Laryngoscope. 2026 Apr; 136(4):1566-1567. PMID: 40530802.

    Read at: PubMed

  • Published 6/12/2025

    Patel AA, Tandler C, Sakai O, Weber PC. Reduced Receipt of Dedicated Computed Tomography With Implementation of a New Temporal Bone Fracture Protocol. Ann Otol Rhinol Laryngol. 2025 Oct; 134(10):763-769. PMID: 40509634.

    Read at: PubMed

Education

  • Albany Medical College, MD
  • Duke University, MBA
  • Washington University in St. Louis, BS/MS